Psychedelics in the C-Suite; A New Frontier in Leadership Development
Wednesday,
March 19,
12:10 PM - 12:30 PM
Bandol 1
Sam Altman, CEO of Open AI, spoke publicly about how a single weekend with ayahuasca had a profound improvement on his mental health and creativity. He’s the latest high-profile CEO to break the stigma of sharing how psychedelic drugs are being leveraged in a competitive business landscape. Despite the overwhelming endorsements and positive press coverage, bringing psychedelics into the workplace can also have unintended consequences. Come curious and ready to learn; psychedelics are going mainstream. As business leaders, it’s imperative that we understand guidelines and guardrails of psychedelic leadership development.

Steven Huang
Director of People, Finance, & IT
Multidisciplinary Association for Psychedelic Studies